(Q48208417)

9 February 2018

title

Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. (English)

1 reference

9 February 2018

1 reference

1 reference

Pamela A Statler

1

1 reference

9 February 2018

Ronald J McPherson

2

1 reference

9 February 2018

Larry A Bauer

3

1 reference

9 February 2018

Brian A Kellert

4

1 reference

9 February 2018

Sandra E Juul

5

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

9 February 2018

published in

Pediatric Research

1 reference

9 February 2018

volume

61

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

671-675

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e31805341dc

exact match

0 references

cites work

Neurodevelopmental outcomes of infants born prematurely

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Perinatal hypoxic-ischemic brain damage: evolution of an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Effect of carbon dioxide on cerebral metabolism during hypoxia-ischemia in the immature rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Regional cerebral blood flow during hypoxia-ischemia in immature rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

EPO's alter ego: erythropoietin has multiple actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Erythropoietin improves functional and histological outcome in neonatal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

Protective effect of erythropoietin in neonatal hypoxic ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31805341DC

10.1203/PDR.0B013E31805341DC

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

Dimensions Publication ID

1036355807

0 references

Fatcat ID

release_o2ruhr36sjh6naa4gc6iudizye

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o2ruhr36sjh6naa4gc6iudizye

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17426655

1 reference

9 February 2018